Meta Stock: Growth, Discount Drive Fresh Buy Thesis
Meta Platforms posts stronger growth in Q1 2026, lifting revenue and margins while the stock trades at a meaningful d...
What Can I Buy With Credit Card Points
Curious about what you can buy with credit card points? Explore a variety of exciting options to make the most of your rewards!
28,188 articles
MSTX Lost Percent From August Peak Spurs Leverage Decay
MSTX, a 2x levered ETF tracking MicroStrategy, tumbled 14% on Friday as payroll data pointed to a stronger labor mark...
QYLD’s $10,000 Problem: Covered-Call Costs vs Nasdaq Gains
Investors chasing steady monthly income via QYLD face a trade-off: the cost of covered-call income can outpace Nasdaq...
UBS Bets on Target's $2B Turnaround Plan for 2026 Outlook
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
Bitcoin Rejected $80K Inflation Fears: Weekly Recap
Bitcoin spent the week wavering around the 80K level, briefly spiking above, then slipping as inflation data and regu...
Wall Street Just Monster Target on Micron Sparks Debate
A top broker unleashes a monster target on Micron, triggering questions about whether wall street just monster pricin...
Beazer Fight Over Standstill Intensifies as Bid Climbs
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
BitMine Buys 61K ETH as Calls Bottom Signals Resilience
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Trump Bought Boeing Stock as 200-Plane China Deal Emerges
A high-stakes aviation deal with China collides with a political stock move tied to a former president. Boeing and GE...
Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Palantir’s 625% Run Sparks Debate Over Value and Risk
Palantir Technologies has delivered a staggering 625% rally since 2020, but a mix of government ties and governance s...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status